Copyright
©The Author(s) 2026.
World J Transplant. Mar 18, 2026; 16(1): 109740
Published online Mar 18, 2026. doi: 10.5500/wjt.v16.i1.109740
Published online Mar 18, 2026. doi: 10.5500/wjt.v16.i1.109740
Table 1 Proposed standardized photoactivated chromophore for infectious keratitis–corneal collagen cross-linking protocols by pathogen type and ulcer depth
| Pathogen type | UVA exposure (fluence, intensity) | Riboflavin concentration | Treatment duration | Rationale/references |
| Bacterial Keratitis | 7.2–10.0 J/cm² at 30 mW/cm² (4–5.5 minutes) | 0.1% iso-osmolar with HPMC, applied every 2 minutes for 15–20 minutes | 20–25 minutes (soak + irradiation) | Higher fluences achieve 97.50%–99.90% bacterial killing ratios for Staphylococcus aureus and Pseudomonas aeruginosa. Accelerated delivery is oxygen-independent, effective for ulcers < 300 μm[37,38] |
| Fungal Keratitis | 7.2–15.0 J/cm² at 30 mW/cm² (4–8.3 minutes) | 0.1% iso-osmolar with HPMC, applied every 2 minutes for 15–20 minutes | 25–30 minutes (soak + irradiation) | Deeper ulcers (33%–67% stroma) require higher fluences due to ultraviolet absorption in opaque corneas. 7.2 J/cm² eradicated resistant cases[40,41] |
| Mixed bacterial/fungal | 10.0 J/cm² at 30 mW/cm² (5.5 minutes) | 0.1% iso-osmolar with HPMC, applied every 2 minutes for 15–20 minutes | 25 minutes (soak + irradiation) | Broad-spectrum efficacy with high fluence targets both pathogens, with proven safety[39] |
| AK | Sequential: Riboflavin/UVA (7.2 J/cm² at 30 mW/cm², 4 minutes) + Rose bengal/green light (0.1–0.2 J/cm² at 532 nm, 15–30 second) | 0.1% riboflavin (15–20 minutes soak) + 0.1% rose bengal (10 minutes soak) | 35–45 minutes (dual soak + irradiation) | Dual-chromophore approach targets resistant AK cysts, leveraging complementary absorption spectra[42] |
| Ulcer depth adjustment | < 100 μm: 7.2 J/cm²; 100–300 μm: 10.0–15.0 J/cm² | As above | As above | Adjust fluence based on AS-OCT-measured depth to ensure ROS penetration in opaque ulcers[35] |
- Citation: Antonopoulou NI, Spyropoulou MS, Papadakos SP, Papavasileiou GN, Dimakis AC. Bridging gaps in corneal ulcer management: Can photoactivated chromophore for infectious keratitis–corneal collagen cross-linking delay or replace therapeutic keratoplasty? World J Transplant 2026; 16(1): 109740
- URL: https://www.wjgnet.com/2220-3230/full/v16/i1/109740.htm
- DOI: https://dx.doi.org/10.5500/wjt.v16.i1.109740
